TENECTASE®
Acute ischemic stroke (3rd‑gen thrombolytic)
ApprovedCommercial
Key Facts
Indication
Acute ischemic stroke (3rd‑gen thrombolytic)
Phase
Approved
Status
Commercial
Company
About Gennova Bio
Indian biotech delivering a portfolio of recombinant therapeutics and mRNA vaccines through innovative, scalable manufacturing.
View full company profile